Building a Precision Oncology Program at Scale

This webinar is on-demand and can be viewed at your convenience.

Molecular cancer testing has found varying but increasing clinical adoption in the practice of cancer diagnostics and care. Often innovation outpaces clinical adoption. Full realization of the benefits of this rapidly advancing field requires more than adoption of testing but also the creation of a comprehensive precision oncology program.

We are proud to sponsor this session, where Stephen Gruber, Vice President at City of Hope National Medical Center and Director of City of Hope’s Center for Precision Medicine, Stacy Gray, Chief of City of Hope’s Division of Clinical Cancer Genomics and Deputy Director of its Center for Precision Medicine, Sumanta “Monty” Pal, Co-Director of the Kidney Cancer Program at City of Hope, and Rick Baehner, M.D., Chief Medical Officer at Exact Sciences Precision Oncology, describe their experience building their precision oncology program. They illustrate how it has improved patient care and clinical outcomes and how they were able to leverage hurdles experienced through the implementation of such programs into opportunities — ultimately delivering benefits for patients and health care professionals.

Key takeaways:

Understand the clinical benefits of a broad scale precision oncology program
Learn about the foreseeable implementation challenges and ways to successfully address them in proactive ways
Be introduced to how precision oncology programs are benefiting the community of patients and healthcare professionals at City of Hope

Presenters

Stephen Gruber, M.D., Ph.D., M.P.H.

Vice President and Director of the Center for Precision Medicine, City of Hope National Medical Center

Stacy Gray, M.D., A.M.

Deputy Director, Center for Precision Medicine, Chief of Clinical Cancer Genomics Division, City of Hope National Medical Center

Sumanta “Monty” Pal, M.D., F.A.S.C.O.

Co-Director of the Kidney Cancer Program and professor in the Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center